BioLife Solutions, Inc. Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31)
BioLife Solutions, Inc. (BLFS) reported Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) of $6.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Income Statement › Other Income
us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGainLoss1 · last filed 2016-02-25
- BioLife Solutions, Inc. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2015-12-31 was $150.00, a 5.06% decline year-over-year.
- BioLife Solutions, Inc. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $789.00.
- BioLife Solutions, Inc. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2015-06-30 was -$441.00.
- BioLife Solutions, Inc. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $5.50K.
- BioLife Solutions, Inc. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for fiscal 2015 was $6.00K.
- BioLife Solutions, Inc. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for fiscal 2014 was -$6.45K.
| Period end | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2015-12-31 | $150.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $939.00 derived: sum of 2 quarters · filed 2016-02-25 | $498.00 derived: sum of 3 quarters · filed 2016-02-25 | $6.00K 10-K · filed 2016-02-25 |
| 2015-09-30 | $789.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $348.00 derived: sum of 2 quarters · filed 2015-11-16 | $5.85K 10-Q · filed 2015-11-16 | $6.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2015-06-30 | -$441.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $5.06K 10-Q · filed 2015-08-06 | $5.22K derived: sum of 3 quarters · filed 2016-02-25 | $2.12K derived: sum of 4 quarters · filed 2016-02-25 |
| 2015-03-31 | $5.50K 10-Q · filed 2015-05-07 | $5.66K derived: sum of 2 quarters · filed 2016-02-25 | $2.56K derived: sum of 3 quarters · filed 2016-02-25 | |
| 2014-12-31 | $158.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$2.94K derived: sum of 2 quarters · filed 2016-02-25 | -$6.45K 10-K · filed 2016-02-25 | |
| 2014-09-30 | -$3.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$6.61K 10-Q · filed 2014-11-06 | ||
| 2014-06-30 | -$3.51K 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |